Latest Insider Transactions at Agilon Health, Inc. (AGL)
This section provides a real-time view of insider transactions for Agilon Health, Inc. (AGL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of agilon health, inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of agilon health, inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2023
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
18,750
-19.08%
|
$337,500
$18.73 P/Share
|
|
Jun 15
2023
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,750
+16.02%
|
$56,250
$3.79 P/Share
|
|
Jun 14
2023
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
18,750
-6.74%
|
$337,500
$18.57 P/Share
|
|
Jun 14
2023
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,750
+5.93%
|
$56,250
$3.53 P/Share
|
|
May 18
2023
|
Cd&R Investment Associates Ix, Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
94,173,804
-48.5%
|
$1,883,476,080
$20.8 P/Share
|
|
May 16
2023
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
25,000
-23.91%
|
$575,000
$23.14 P/Share
|
|
May 16
2023
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+19.3%
|
$75,000
$3.0 P/Share
|
|
May 15
2023
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
25,000
-23.91%
|
$575,000
$23.79 P/Share
|
|
May 15
2023
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+19.3%
|
$75,000
$3.0 P/Share
|
|
May 15
2023
|
Cd&R Investment Associates Ix, Ltd. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
437,504
-0.22%
|
-
|
|
May 09
2023
|
Veeral Desai Chief Strategy & Dev. Officer |
SELL
Open market or private sale
|
Direct |
4,500
-1.48%
|
$117,000
$26.15 P/Share
|
|
May 09
2023
|
Veeral Desai Chief Strategy & Dev. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+1.46%
|
$13,500
$3.0 P/Share
|
|
Apr 20
2023
|
Veeral Desai Chief Strategy & Dev. Officer |
SELL
Open market or private sale
|
Direct |
500
-0.17%
|
$13,000
$26.15 P/Share
|
|
Apr 20
2023
|
Veeral Desai Chief Strategy & Dev. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+0.17%
|
$1,500
$3.0 P/Share
|
|
Apr 19
2023
|
Veeral Desai Chief Strategy & Dev. Officer |
SELL
Open market or private sale
|
Direct |
5,000
-0.82%
|
$135,000
$27.33 P/Share
|
|
Apr 19
2023
|
Veeral Desai Chief Strategy & Dev. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.62%
|
$15,000
$3.0 P/Share
|
|
Apr 18
2023
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
25,000
-23.91%
|
$700,000
$28.05 P/Share
|
|
Apr 18
2023
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+19.3%
|
$75,000
$3.0 P/Share
|
|
Apr 17
2023
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
25,000
-12.15%
|
$700,000
$28.12 P/Share
|
|
Apr 17
2023
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+10.18%
|
$50,000
$2.0 P/Share
|
|
Apr 14
2023
|
Steven Sell CEO & President |
SELL
Payment of exercise price or tax liability
|
Direct |
4,216
-5.02%
|
$118,048
$28.46 P/Share
|
|
Apr 14
2023
|
Steven Sell CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
35,138
+29.52%
|
-
|
|
Apr 14
2023
|
Benjamin Shaker Chief Markets Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,043
-3.68%
|
$85,204
$28.46 P/Share
|
|
Apr 14
2023
|
Benjamin Shaker Chief Markets Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,961
+21.01%
|
-
|
|
Apr 14
2023
|
Girish Venkatachaliah Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,357
-3.59%
|
$37,996
$28.46 P/Share
|
|
Apr 14
2023
|
Girish Venkatachaliah Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,961
+36.78%
|
-
|
|
Apr 14
2023
|
Ronald A Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,622
+0.23%
|
-
|
|
Apr 14
2023
|
John William Wulf Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,622
+4.18%
|
-
|
|
Apr 14
2023
|
Timothy Bensley Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,871
-7.55%
|
$80,388
$28.46 P/Share
|
|
Apr 14
2023
|
Timothy Bensley Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,981
+22.4%
|
-
|
|
Apr 14
2023
|
Veeral Desai Chief Strategy & Dev. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,497
-1.15%
|
$97,916
$28.46 P/Share
|
|
Apr 14
2023
|
Veeral Desai Chief Strategy & Dev. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,353
+8.0%
|
-
|
|
Apr 14
2023
|
Priscilla Kasenchak Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,393
+36.19%
|
-
|
|
Apr 14
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,312
-2.19%
|
$36,736
$28.46 P/Share
|
|
Apr 14
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,393
+6.84%
|
-
|
|
Apr 14
2023
|
Sharad Mansukani Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,622
+0.45%
|
-
|
|
Apr 14
2023
|
Diana Mckenzie Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,622
+45.63%
|
-
|
|
Apr 14
2023
|
Karen Mc Loughlin Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,622
+25.94%
|
-
|
|
Apr 14
2023
|
Clay Richards Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,622
+12.0%
|
-
|
|
Apr 14
2023
|
Jeffrey A. Schwaneke Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,622
+36.86%
|
-
|
|
Mar 24
2023
|
Veeral Desai Chief Strategy & Dev. Officer |
SELL
Open market or private sale
|
Direct |
97,290
-26.01%
|
$2,724,120
$28.7 P/Share
|
|
Mar 24
2023
|
Veeral Desai Chief Strategy & Dev. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
97,290
+20.64%
|
$291,870
$3.0 P/Share
|
|
Mar 23
2023
|
Veeral Desai Chief Strategy & Dev. Officer |
SELL
Open market or private sale
|
Direct |
22,710
-7.58%
|
$635,880
$28.71 P/Share
|
|
Mar 23
2023
|
Veeral Desai Chief Strategy & Dev. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,710
+7.05%
|
$68,130
$3.0 P/Share
|
|
Mar 23
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
8,094
-12.74%
|
$226,632
$28.04 P/Share
|
|
Mar 23
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,094
+11.3%
|
$64,752
$8.99 P/Share
|
|
Mar 22
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
SELL
Open market or private sale
|
Direct |
8,094
-12.74%
|
$218,538
$27.84 P/Share
|
|
Mar 22
2023
|
Benjamin Kornitzer Chief Med. & Quality Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,094
+11.3%
|
$64,752
$8.99 P/Share
|
|
Mar 16
2023
|
Benjamin Shaker Chief Markets Officer |
SELL
Open market or private sale
|
Direct |
25,000
-10.78%
|
$625,000
$25.36 P/Share
|
|
Mar 16
2023
|
Benjamin Shaker Chief Markets Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+22.6%
|
$25,000
$1.0 P/Share
|